Ontology highlight
ABSTRACT: Importance
Recurrent and/or metastatic head and neck cancer is usually incurable. Implementation of precision oncology for these patients has been limited by incomplete understanding of the molecular alterations underlying advanced disease. At the same time, the molecular profiles of many rare head and neck cancer types are unknown. These significant gaps in knowledge need to be addressed to rationally devise new therapies.Objective
To illuminate the distinct biology of recurrent and metastatic head and neck cancers and review implementation of precision oncology for patients with advanced disease.Design, setting, and participants
After exclusions, 151 patients with advanced, treatment-resistant head and neck tumors, including squamous cell carcinoma (HNSCC), adenoi
SUBMITTER: Morris LGT
PROVIDER: S-EPMC5253129 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature